0.8537
60 Degrees Pharmaceuticals Inc stock is traded at $0.8537, with a volume of 94,402.
It is down -2.32% in the last 24 hours and down -30.99% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$0.874
Open:
$0.9
24h Volume:
94,402
Relative Volume:
0.73
Market Cap:
$3.61M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.0856
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
-12.30%
1M Performance:
-30.99%
6M Performance:
-62.56%
1Y Performance:
-89.65%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.8537 | 3.70M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
CEO Makes Bold Move with Major Stock Purchase in 60 Degrees Pharmaceuticals! - TipRanks
Dow, 60 degrees Pharmaceuticals CEO, buys $12k in SXTP stock - Investing.com India
60 Degrees Pharma to expand sales efforts after positive pilot results - Investing.com
60 Degrees Pharmaceuticals announces expansion of Arakoda sales and marketing in 2026 - marketscreener.com
60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026 - TradingView — Track All Markets
60 Degrees Pharma (NASDAQ: SXTP) to Double ARAKODA Sales Reps, Add Babesiosis Trial Sites - Stock Titan
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - Daytona Beach News-Journal
60 Degrees Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Gains Report: Can 60 Degrees Pharmaceuticals Inc stock maintain growth trajectory2025 Analyst Calls & Technical Pattern Based Signals - moha.gov.vn
Day Trade: Why 60 Degrees Pharmaceuticals Inc stock is considered a top pickJuly 2025 Rallies & Stock Portfolio Risk Management - moha.gov.vn
Can 60 Degrees Pharmaceuticals Inc. stock maintain growth trajectoryMarket Trend Review & Daily Stock Momentum Reports - Newser
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentReal-Time Stock Alerts & Rapid Capital Trading Tips - earlytimes.in
Will 60 Degrees Pharmaceuticals Inc. stock deliver long term returnsNew Guidance & Weekly Breakout Opportunity Watchlist - BỘ NỘI VỤ
What You Should Know About Kohinoor Foods Limiteds Profitability RatiosMarket Volatility Update & Small Investment Portfolio - earlytimes.in
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given New $2.80 Price Target at Ascendiant Capital Markets - Defense World
Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pickLayoff News & Smart Swing Trading Alerts - moha.gov.vn
Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Ascendiant Capital Maintains 60 Degrees Pharmaceuticals (SXTP) Buy Recommendation - Nasdaq
Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 20252025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ
How 60 Degrees Pharmaceuticals Inc. stock reacts to job market dataMarket Performance Report & Daily Stock Trend Watchlist - moha.gov.vn
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
60 Degrees Pharma begins enrollment for chronic babesiosis study By Investing.com - Investing.com Nigeria
60 Degrees Pharma begins enrollment for chronic babesiosis study - Investing.com India
60 Degrees Pharmaceuticals announces clinical site now open for patient enrollment - MarketScreener
60 Degrees Pharmaceuticals Launches First-Ever Study for Tafenoquine in Chronic Babesiosis Patients - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine - The Manila Times
60 Degrees Pharmaceuticals Announces Clinical Site Now Open - GlobeNewswire
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 2025 - newser.com
How resilient is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock in market downturnsPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock supported by innovation pipeline2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded at Zacks Research - Defense World
How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs in high volatility markets2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Update Report & High Yield Stock Recommendations - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock sustain free cash flow growthJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investors2025 Volatility Report & Expert Curated Trade Setups - newser.com
What technical charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating margins2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsSell Signal & AI Enhanced Trade Execution Alerts - newser.com
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):